1. Home
  2. WWR vs MDCX Comparison

WWR vs MDCX Comparison

Compare WWR & MDCX Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.

  • Machine Learning Prediction
  • ML Decision
  • WWR
  • MDCX
  • Stock Information
  • Founded
  • WWR 1977
  • MDCX 2008
  • Country
  • WWR United States
  • MDCX United States
  • Employees
  • WWR N/A
  • MDCX N/A
  • Industry
  • WWR Metal Mining
  • MDCX
  • Sector
  • WWR Basic Materials
  • MDCX
  • Exchange
  • WWR Nasdaq
  • MDCX Nasdaq
  • Market Cap
  • WWR 170.7M
  • MDCX 50.8M
  • IPO Year
  • WWR N/A
  • MDCX N/A
  • Fundamental
  • Price
  • WWR $2.04
  • MDCX $2.36
  • Analyst Decision
  • WWR Strong Buy
  • MDCX Strong Buy
  • Analyst Count
  • WWR 2
  • MDCX 2
  • Target Price
  • WWR $2.00
  • MDCX $23.50
  • AVG Volume (30 Days)
  • WWR 15.1M
  • MDCX 377.2K
  • Earning Date
  • WWR 11-14-2025
  • MDCX 11-22-2025
  • Dividend Yield
  • WWR N/A
  • MDCX N/A
  • EPS Growth
  • WWR N/A
  • MDCX N/A
  • EPS
  • WWR N/A
  • MDCX N/A
  • Revenue
  • WWR N/A
  • MDCX N/A
  • Revenue This Year
  • WWR N/A
  • MDCX N/A
  • Revenue Next Year
  • WWR N/A
  • MDCX N/A
  • P/E Ratio
  • WWR N/A
  • MDCX N/A
  • Revenue Growth
  • WWR N/A
  • MDCX N/A
  • 52 Week Low
  • WWR $0.45
  • MDCX $1.79
  • 52 Week High
  • WWR $3.75
  • MDCX $8.94
  • Technical
  • Relative Strength Index (RSI)
  • WWR 58.73
  • MDCX 49.17
  • Support Level
  • WWR $0.87
  • MDCX $2.33
  • Resistance Level
  • WWR $3.75
  • MDCX $2.48
  • Average True Range (ATR)
  • WWR 0.42
  • MDCX 0.19
  • MACD
  • WWR 0.08
  • MDCX -0.02
  • Stochastic Oscillator
  • WWR 39.97
  • MDCX 38.46

About WWR Westwater Resources Inc.

Westwater Resources Inc focused on developing battery-grade natural graphite materials. The company is having one project which is the Westwater's coosa project which is currently used for the mining and extraction of graphite.

About MDCX Medicus Pharma Ltd. Common Stock

Medicus Pharma Ltd is a clinical-stage holding company focused on investing in and accelerating novel life sciences and bio-technology companies through FDA-approved clinical trials. The Company focuses on meeting the unmet need to improve patient safety and efficacy.

Share on Social Networks: